Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats. They strive to impact patients’ lives by advancing innovative treatments for severe diseases. The firm backs great teams with development programs that aim to make a true difference for patients.
Preferred startup development maturity for initial funding deployment.
Drug Development, Biological Drugs, Next-generation Biological Drugs, Drug Formats, Innovative Therapeutics, Severe Diseases
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...